Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FORESEE: Functional Precision Oncology for Metastatic Breast Cancer: a Feasibility Trial

NCT04450706 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT04450706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04450706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FORESEE: Functional Precision Oncology for Metastatic Breast Cancer: a Feasibility Trial
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Completed
Start date
February 16, 2021
Completion date
September 5, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-negative breast cancer